Japan-based Fujikura Kasei will exercise its option to licence the midkine (MK) diagnostic technology and will make a JPY40 million ($403,000) payment as milestone fee to Australia-based Cellmid. The companies signed the option to license ...
Fujikura has inked a licensing agreement with Micro-Imaging Solutions (MIS) to jointly market nano-sized, complementary metal-oxide semiconductor, or CMOS, based endoscopes. This agreement focuses on the commercial manufacturing ...
Tags: Micro-Imaging, Medicine
CO?laser heat source, advanced feedback control and stabilisation techniques have been specially developed to improve performance and productivity Chessington, UK. Fujikura Europe, one of the world's leading manufacturers of fibre ...
Tags: Fujikura, Glass Processor, Glass
Australian biotechnology company Cellmid has entered into an option agreement with Japanese company Fujikura Kasei. Under the option to license agreement, Cellmid will supply its proprietary anti-midkine diagnostic antibodies for ...
Tags: Cellmid, Fujikura Kasei, anti-midkine diagnostic antibodies